Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Oct 26, 2022

BUY
$7.9 - $10.19 $87,271 - $112,568
11,047 New
11,047 $88,000
Q3 2020

Nov 02, 2020

SELL
$8.57 - $12.69 $3,308 - $4,898
-386 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $3,134 - $5,064
386 New
386 $5,000
Q4 2019

Sep 02, 2020

SELL
$6.53 - $10.72 $1,710 - $2,808
-262 Closed
0 $0
Q3 2019

Nov 15, 2019

BUY
$6.16 - $9.6 $227 - $355
37 Added 16.44%
262 $2,000
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $3,897 - $7,545
-480 Reduced 68.09%
225 $2,000
Q1 2019

May 16, 2019

BUY
$15.58 - $20.01 $10,983 - $14,107
705 New
705 $11,000
Q4 2018

Feb 13, 2019

SELL
$14.59 - $23.84 $25,692 - $41,982
-1,761 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$21.06 - $25.65 $37,086 - $45,169
1,761 New
1,761 $38,000
Q4 2017

Feb 14, 2018

SELL
$11.23 - $19.1 $3,009 - $5,118
-268 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$15.41 - $32.17 $4,129 - $8,621
268
268 $5,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Balentine LLC Portfolio

Follow Balentine LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.